Q&A on Barriers to HIV PrEP: Pharmacist Perspectives

06/27/23 • 10 min

In this episode, Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP, and Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES, discuss key considerations to barriers to PrEP uptake, including:

Limited data on “on-demand” PrEP in cisgender women
Strategies on improving communication with non‒English-speaking populations
Role of pharmacists with injectable PrEP
CDC PrEP guideline recommendations on routine HIV-1 RNA testing
Engaging with pregnant persons who might want access to PrEP in the pharmacy setting
Oral PrEP efficacy based on adherence in cisgender women, including recent data presented at CROI 2023 by Marrazzo and colleagues

Presenters:

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Associate Professor
Department of Pharmacy Practice
Midwestern University College of Pharmacy, Downers Grove Campus
Downers Grove, Illinois
System-Level HIV/ID Clinical Pharmacist
Ambulatory Pharmacy
Northwestern Medicine
Wheaton, Illinois

Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES
Assistant Professor
Department of Pharmacotherapy and Clinical Research
University of South Florida
Clinical Pharmacist
Tampa General Medical Group
Tampa, Florida

Content based on an online CME program supported by an independent educational grant from ViiV Healthcare.

Link to full program:
https://bit.ly/3ZjSFhg

Downloadable slides:
https://bit.ly/3PsFNDt

In this episode, Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP, and Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES, discuss key considerations to barriers to PrEP uptake, including:

Limited data on “on-demand” PrEP in cisgender women
Strategies on improving communication with non‒English-speaking populations
Role of pharmacists with injectable PrEP
CDC PrEP guideline recommendations on routine HIV-1 RNA testing
Engaging with pregnant persons who might want access to PrEP in the pharmacy setting
Oral PrEP efficacy based on adherence in cisgender women, including recent data presented at CROI 2023 by Marrazzo and colleagues

Presenters:

Content based on an online CME program supported by an independent educational grant from ViiV Healthcare.

Link to full program:
https://bit.ly/3ZjSFhg

Downloadable slides:
https://bit.ly/3PsFNDt

Previous Episode

Older Adults: Overcoming HBV Barriers

In this episode, Robert S. Brown, Jr., MD, MPH; Nancy Reau, MD; and Eric, a person living with chronic hepatitis B, discuss solutions for overcoming barriers to HBV care in older adults, including:

Awareness of HBV and CHB in older adults
Updated HBV screening and vaccination recommendations
Monitoring of renal and bone disease
Adjustment of monitoring and treatment as a person with HBV ages

Presenters:
Robert S. Brown, Jr., MD, MPH
Vincent Astor Distinguished
Professor of Medicine
Chief, Division of Gastroenterology and Hepatology
Weill Cornell Medicine
New York, New York
Nancy Reau, MD
Professor of Medicine
Chief, Section of Hepatology
Associate Director, Solid Organ Transplantation
Richard B. Capps Chair of Hepatology
Rush University Medical Center
Chicago, Illinois

Eric, person living with chronic hepatitis B

Link to downloadable slides: please link to VM404 downloadable slides when ready

Link to program:
bit.ly/3L3Kz6l

Next Episode

Answering the Questions on Which HIV PrEP for Which Patient: Latesha Elopre and Jason Farley

In this episode, Latesha Elopre, MD, MSPH, and Jason Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN, answer questions about HIV PrEP including:

How long someone can receive PrEP and the monitoring that is needed over time
Recommendations for monitoring bone health while receiving oral PrEP
Treatment as prevention and PrEP efficacy data and options for people who inject drugs
The role of circumcision in HIV prevention
The use of PrEP in pregnancy
Concern for ART resistance if someone seroconverts while receiving PrEP, especially when using nondaily PrEP options
The possibility of using FTC/TAF on demand
Inequities in adherence and persistence
Cost considerations with different PrEP modalities
Recommendations for hospitalized patients receiving PrEP
PrEP considerations for patients with renal dysfunction and higher BMIs
PrEP efficacy based on site of exposure

Presenters:

Latesha Elopre, MD, MSPH
Associate Professor
Division of Infectious Diseases
Assistant Dean of Diversity and Inclusion
General Medical Education
University of Alabama at Birmingham
Birmingham, Alabama

Jason Farley, PhD, MPH, ANP-BC, FAAN, FAANP, AACRN
Professor
School of Nursing
Johns Hopkins University
Nurse Practitioner
Department of Infectious Diseases
John G. Bartlett Specialty Practice
Baltimore, Maryland

Link to full program:
https://bit.ly/3Fqdgs9